ULTRAGENYX PHARMACEUTICAL INC. Public Float
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Public Float of $3.40 billion as of 2025-06-30, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-18
- 2025-06-30: Entity Public Float $3.40B.
- 2024-06-30: Entity Public Float $3.70B.
- 2023-06-30: Entity Public Float $3.10B.
- 2022-06-30: Entity Public Float $3.30B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.40B 10-K · filed 2026-02-18 |
| 2024-06-30 | $3.70B 10-K · filed 2025-02-19 |
| 2023-06-30 | $3.10B 10-K · filed 2024-02-21 |
| 2022-06-30 | $3.30B 10-K · filed 2023-02-17 |
| 2021-06-30 | $6.50B 10-K · filed 2022-02-15 |
| 2020-06-30 | $4.70B 10-K · filed 2021-02-12 |
| 2019-06-30 | $2.70B 10-K · filed 2020-02-14 |
| 2018-06-30 | $3.20B 10-K · filed 2019-02-20 |
| 2017-06-30 | $2.60B 10-K · filed 2018-02-21 |
| 2016-06-30 | $1.90B 10-K · filed 2017-02-17 |
| 2015-06-30 | $2.30B 10-K · filed 2016-02-26 |
| 2014-06-30 | $910.60M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |